These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 18046857)
1. The benefits of combined treatment with corticosteroids and long-acting beta agonists. Singh D Int J Chron Obstruct Pulmon Dis; 2006; 1(3):207-8. PubMed ID: 18046857 [No Abstract] [Full Text] [Related]
3. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease. Sin DD; Johnson M; Gan WQ; Man SF Curr Pharm Des; 2004; 10(28):3547-60. PubMed ID: 15579052 [TBL] [Abstract][Full Text] [Related]
4. Clinical Inquiry: what are the benefits and risks of inhaled corticosteroids for COPD? Hamilton T; Miller JB; Vincent EC; St Anna L J Fam Pract; 2014 May; 63(5):276-8. PubMed ID: 24795909 [No Abstract] [Full Text] [Related]
5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
6. [Role of inhaled corticosteroids in the management of COPD]. Chazan R Pneumonol Alergol Pol; 2009; 77(2):186-91. PubMed ID: 19462354 [No Abstract] [Full Text] [Related]
7. Triple Therapy Is Also Effective in Real-World When Used in Chronic Obstructive Pulmonary Disease Patients Who Are Frequent Exacerbators. Cazzola M; Celli B Respiration; 2021; 100(2):93-95. PubMed ID: 33454710 [No Abstract] [Full Text] [Related]
8. Optimal treatment of chronic obstructive pulmonary disease: the search for the magic combination of inhaled bronchodilators and corticosteroids. Criner GJ Ann Intern Med; 2007 Apr; 146(8):606-8. PubMed ID: 17438320 [No Abstract] [Full Text] [Related]
9. [Inhaled combination therapy with corticosteroids and long-acting beta-2 agonists in chronic obstructive pulmonary disease]. Chen YH; Yao WZ; Zhao MW Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):928-30. PubMed ID: 19134412 [No Abstract] [Full Text] [Related]
10. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Hanania NA Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761 [TBL] [Abstract][Full Text] [Related]
11. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Kiri VA; Vestbo J; Pride NB; Soriano JB Eur Respir J; 2004 Jul; 24(1):190-1; author reply 191-2. PubMed ID: 15293626 [No Abstract] [Full Text] [Related]
12. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915 [TBL] [Abstract][Full Text] [Related]
14. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Fuso L; Mores N; Valente S; Malerba M; Montuschi P Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722 [TBL] [Abstract][Full Text] [Related]
15. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!]. Rochat T Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880 [TBL] [Abstract][Full Text] [Related]
17. Long acting beta2 agonists: are they safe? Wijesiriwardena B Ceylon Med J; 2006 Dec; 51(4):129-31. PubMed ID: 17461321 [No Abstract] [Full Text] [Related]